Regeneron's genetic disorder treatment meets main goal of late-stage trial-February 2024-www.financetom.com

Regeneron's genetic disorder treatment meets main goal of late-stage trial

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Regeneron's genetic disorder treatment meets main goal of late-stage trial

Sep 17, 2025 6:47 AM

Sept 17 (Reuters) - Regeneron Pharmaceuticals ( REGN )

said on Wednesday its experimental treatment for patients with a

rare genetic disorder affecting mobility has met the main goal

of a late-stage trial.

Previous page： Burger King Parent Restaurant Brands Stock Slips On Q3 Earnings Miss; On Track To Deliver 8%+ System-Wide Sales Growth Next page： Fresenius Medical Care Q3 Earnings Rise, Revenue Decreases

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Burger King Parent Restaurant Brands Stock Slips On Q3 Earnings Miss; On Track To Deliver 8%+ System-Wide Sales Growth

Nov 5, 2024

Restaurant Brands International Inc. ( QSR ) shares are trading lower in the premarket session on Tuesday after the company reported its third-quarter results. Restaurant Brands reported adjusted earnings per share of 93 cents, missing the street view of 95 cents. Quarterly sales of $2.291 billion missed the analyst consensus estimate of $2.307 billion. The company reported consolidated comparable sales...

Fresenius Medical Care Q3 Earnings Rise, Revenue Decreases

Nov 5, 2024

08:11 AM EST, 11/05/2024 (MT Newswires) -- Fresenius Medical Care ( FMS ) reported Q3 earnings Tuesday of 0.73 euros ($0.67) per share, up from 0.29 euros a year earlier. A single analyst polled by Capital IQ expected 0.68 euros. Revenue for the quarter ended Sept. 30 was 4.76 billion euros, down from 4.94 billion euros a year earlier. Analysts...

Scotiabank Previews Tuesday's Bank of Canada Summary of Deliberations of The October Policy Meeting

Nov 5, 2024

07:55 AM EST, 11/05/2024 (MT Newswires) -- Bank of Canada will release its Summary of Deliberations from October's policy meeting at 1:30 p.m. ET Tuesday, noted Scotiabank. The BoC's Summary of Deliberations might inform the range of discussion around 25bps or 50bps at the last meeting and the potential range of viewpoints on the Governing Council, but Scotiabank doubts investors...

Market Chatter: KKR Secures Over One-Third of Fuji Soft After First Stage of Tender Offer

Nov 5, 2024

08:06 AM EST, 11/05/2024 (MT Newswires) -- KKR & Co Inc ( KKR ) has secured over one-third of Fuji Soft after the private equity company completed the first stage of its tender offer, Bloomberg reported Tuesday, citing people familiar with the matter. KKR did not immediately reply to a request for comment from MT Newswires. (Market Chatter news is...